Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 84Colorectal Neoplasms 42Rectal Neoplasms 40Carcinoma, Non-Small-Cell Lung 27Esophageal Neoplasms 24Esophageal Squamous Cell Carcinoma 23Stomach Neoplasms 19Lung Neoplasms 19Squamous Cell Carcinoma of Head and Neck 17Colonic Neoplasms 17Pancreatic Neoplasms 15Adenocarcinoma Of Esophagus 15Sarcoma 14Prostatic Neoplasms 13Neoplasm Metastasis 13Neoplasms 12Head and Neck Neoplasms 12Ovarian Neoplasms 11Carcinoma, Hepatocellular 11Inflammatory Breast Neoplasms 9Uterine Cervical Neoplasms 8Urinary Bladder Neoplasms 8Osteosarcoma 8Fallopian Tube Neoplasms 8Central Nervous System Neoplasms 8Carcinoma, Intraductal, Noninfiltrating 8Kidney Neoplasms 7Multiple Myeloma 6Glioblastoma 6Carcinoma, Renal Cell 6

Interventions

Fulvestrant 6Letrozole 4exemestane 3dalpiciclib 3Trastuzumab 3Docetaxel 3Capecitabine 3Anastrozole 3ribociclib 2palbociclib 2fluzoparib 2apatinib 2Irinotecan 2Gemcitabine 2tusamitamab ravtansine 1trastuzumab deruxtecan 1sacituzumab govitecan 1pyrotinib 1pegfilgrastim 1patritumab deruxtecan 1olaparib 1nirogacestat 1margetuximab 1irinotecan sucrosofate 1abemaciclib 1Zoledronic Acid 1Vinorelbine 1Tamoxifen 1Rogaratinib 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Breast Cancer Metastatic × Neoadjuvant Therapy × Clear all
NCT06876636 2025-07-29

Zoledronic Acid Combined With EC-T for Triple-Negative Breast Cancer

Xijing Hospital

Phase NA Active not recruiting
99 enrolled
Breast

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡